Duopharma Biotech Bhd

Duopharma Biotech Bhd

7148 · KLSE · Healthcare / Drug Manufacturers - Specialty & Generic

1.10MYR+0.01 (+0.92%)

Price History

Full chart

Market Stats

Previous Close1.09
Open1.08
Day Range1.08 – 1.10
52-Week Range1.14 – 1.52
Volume70.60K
Market Cap1.10B
P/E (TTM)10.36
Forward P/E10.49
EPS0.11
Dividend Yield3.99%
Beta0.36
50-Day Avg1.23
200-Day Avg1.29

About

Duopharma Biotech Berhad, together with its subsidiaries, researches, develops, manufactures, markets, sells, imports, and distributes pharmaceutical products and medicines in Malaysia and internationally. It offers consumer healthcare products, including vitamins, minerals, and supplements under the Flavettes, PROVITON, PROVITON STR, CHAMPS, and Naturalle brand names; analgesics and antitussives under the Uphamol, Uphacol, and Uphaplast brand names; eyecare products under the Eye Glo brand name; antacids under the Alucid brand name; joint pain products under the Donna brand name; skincare products under Dermoplex brand name; cosmeceuticals under the IRORO Nutreatment brand name; and functional food under the CHAMPS Nutribar and PROVITON STR Powerz brand names. The company also provides generic drugs for various therapeutic areas, such as cardiovascular, dermatology, hormonal, respiratory, sensory and nervous system, musculoskeletal, anti-infectives, and others; and specialty pharmaceutical drugs for targeted conditions, biosimilar products, and medical devices and consumables for the treatment of diabetes, cancer, cardiovascular, renal, and other diseases. In addition, it engages in the development of small molecules and biologic therapies for the treatment of Alzheimer's disease; digital therapeutics; and stem cell therapies. Further, the company is involved in property management and services; and distribution of chemical products. It exports its products. The company was formerly known as CCM Duopharma Biotech Berhad and changed its name to Duopharma Biotech Berhad in February 2019. Duopharma Biotech Berhad was founded in 1978 and is headquartered in Kuala Lumpur, Malaysia.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Wan Amir-Jeffery Bin Wan Abdul Majid
  • Employees1.96K
  • HeadquartersCIMB HUB, Kuala Lumpur, Malaysia, 50250, Malaysia
  • Websitehttps://duopharmabiotech.com

Leadership

  • Mr. Wan Amir-Jeffery Bin Wan Abdul MajidCEO & Principal Executive Officer · b. 1972
  • Ms. Rohayu Rosnani Binti Mohd AdananChief Financial Officer · b. 1980
  • Mr. Ibrahim Hussin SallehChief Legal Officer & Group Company Secretary · b. 1968
  • Ms. Sabrina Binti HaronChief Compliance Officer · b. 1981
  • Mr. Krisnakumara ReddiChief Manufacturing & Sustainability Officer · b. 1970
  • Mr. Shamsul Idham Bin A. IahadChief Consumer Healthcare Officer · b. 1974
  • Mr. Wan Ahmad Nizam Bin Wan Mohd. SallehGroup Head of Risk Management & Integrity · b. 1974
  • Ms. Priya Darshini AsokanChief Innovation Officer · b. 1983
  • Ms. Noor Aida Binti JaafarChief Commercial Officer · b. 1975

Financials

Income Statement

Currency: MYR2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue105.10M115.55M122.87M123.77M131.44M138.13M135.31M162.41M176.96M269.79M312.94M467.99M498.72M576.46M569.90M639.17M696.72M704.73M813.70M931.69M
Growth (%)-+9.94%+6.34%+0.73%+6.20%+5.09%-2.04%+20.02%+8.96%+52.46%+15.99%+49.55%+6.57%+15.59%-1.14%+12.16%+9.00%+1.15%+15.46%+14.50%
Cost of Revenue48.15M52.20M62.24M61.88M71.94M74.85M72.36M95.51M95.33M140.88M168.81M281.10M294.24M344.39M336.70M385.19M416.90M436.40M512.16M568.55M
Gross Profit56.95M63.35M60.63M61.89M59.50M63.28M62.95M66.90M81.63M128.91M144.13M186.89M204.48M232.07M233.20M253.98M279.82M268.33M301.54M363.14M
Gross Margin54.19%54.83%49.34%50.01%45.27%45.81%46.52%41.19%46.13%47.78%46.06%39.93%41.00%40.26%40.92%39.74%40.16%38.08%37.06%38.98%
Operating Expense20.31M22.40M25.69M24.11M24.58M28.69M27.35M26.71M34.86M78.73M111.34M132.56M139.20M154.42M151.34M165.22M186.91M187.46M200.89M216.65M
Operating Income36.64M40.95M34.94M37.78M34.92M34.59M35.60M40.19M46.77M50.19M32.80M54.32M65.28M77.64M81.86M88.76M92.91M80.87M100.65M146.49M
Operating Margin34.86%35.44%28.43%30.53%26.57%25.04%26.31%24.74%26.43%18.60%10.48%11.61%13.09%13.47%14.36%13.89%13.34%11.48%12.37%15.72%
EBITDA36.64M45.55M39.69M42.87M40.22M40.93M42.67M48.27M55.21M73.10M59.53M81.16M92.12M105.96M111.75M121.91M130.63M124.00M152.01M185.28M
EBITDA Margin34.86%39.42%32.30%34.64%30.60%29.63%31.54%29.72%31.20%27.10%19.02%17.34%18.47%18.38%19.61%19.07%18.75%17.60%18.68%19.89%
Net Income28.98M32.04M27.40M30.23M28.67M26.70M26.01M32.27M35.27M36.39M26.83M42.46M47.64M55.27M58.61M65.68M70.11M52.65M62.65M87.46M
Net Income Margin27.57%27.73%22.30%24.43%21.81%19.33%19.23%19.87%19.93%13.49%8.57%9.07%9.55%9.59%10.28%10.28%10.06%7.47%7.70%9.39%
R&D---------6.30M9.70M10.26M11.48M-------
R&D as % of Total Revenue---------2.34%3.10%2.19%2.30%-------
Interest Expense1.45M1.59M402.00K432.00K490.00K231.00K401.00K307.00K438.00K3.60M5.34M5.00M7.55M7.96M6.53M6.44M9.10M18.20M26.59M24.75M
Interest Expense % of Total Revenue1.38%1.38%0.33%0.35%0.37%0.17%0.30%0.19%0.25%1.34%1.71%1.07%1.51%1.38%1.14%1.01%1.31%2.58%3.27%2.66%

Balance Sheet

Currency: MYR2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets159.01M127.33M150.38M173.36M196.48M197.52M198.03M205.65M222.48M633.45M661.46M705.24M836.38M919.80M1.06B1.16B1.22B1.35B1.38B1.45B
Total Liabilities13.58M13.12M19.83M30.63M38.61M33.08M27.53M23.00M28.85M183.73M206.95M225.38M355.34M390.05M414.61M540.13M566.70M658.01M667.85M690.68M
Total Equity145.43M114.21M130.55M142.74M157.87M164.44M170.50M182.65M193.63M449.72M454.52M479.87M481.04M529.75M643.82M624.00M655.22M687.12M709.15M757.62M
Cash54.36M9.39M18.42M27.00M24.73M8.58M14.14M18.88M18.30M143.51M114.81M96.02M98.25M120.67M158.03M137.98M157.64M270.50M264.55M290.87M
Total Debt---15.43M18.75M10.42M5.34M--122.76M113.30M127.44M243.49M266.00M303.33M403.84M431.60M548.85M515.82M492.90M
Net Debt-54.36M-9.39M-18.42M-11.57M-5.98M1.83M-8.80M-18.88M-18.30M-20.75M-1.52M31.42M145.24M145.33M145.31M265.86M273.97M278.35M247.97M202.02M

Cash Flow

Currency: MYR2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow27.04M25.10M26.46M27.20M40.04M19.37M38.49M39.53M35.97M-50.88M33.24M56.05M72.33M66.96M71.35M43.20M70.27M51.55M82.16M112.71M
Investing Cash Flow-783.00K-6.81M-6.36M-16.00M-25.15M-7.05M-7.56M-9.66M-12.26M-147.28M-30.45M-71.87M-170.35M-59.42M-61.43M-115.86M-69.50M-45.98M-26.27M-32.99M
Financing Cash Flow-24.30M-63.26M-11.06M-2.62M-17.15M-28.46M-25.37M-25.13M-24.29M324.09M-31.78M-3.99M100.41M15.04M27.83M52.37M18.20M107.52M-62.42M-54.26M
Capital Expenditure4.60M8.50M6.89M24.57M25.90M7.42M10.35M8.84M12.43M41.42M34.68M74.59M92.75M60.89M65.62M115.01M71.02M39.56M32.73M26.75M
Free Cash Flow22.44M16.59M19.57M2.63M14.14M11.95M28.13M30.69M23.55M-92.29M-1.44M-18.54M-20.42M6.07M5.73M-71.80M-756.00K11.99M49.43M85.95M
Dividends Paid24.48M63.33M11.11M18.05M20.48M20.13M19.96M20.13M24.29M31.38M22.32M18.13M13.16M6.06M7.23M44.96M8.20M8.85M26.93M33.67M
FCF to OCF82.99%66.12%73.97%9.67%35.31%61.70%73.10%77.63%65.45%181.41%-4.34%-33.08%-28.23%9.06%8.03%-166.19%-1.08%23.26%60.16%76.26%
Dividend Paid to FCF109.07%381.64%56.74%686.46%144.83%168.43%70.93%65.59%103.18%-34.00%-1547.64%-97.80%-64.46%99.87%126.15%-62.62%-1085.05%73.80%54.49%39.17%

Earnings

Report DateSep 30, 2002Dec 31, 2002Mar 31, 2003Mar 31, 2005Jun 30, 2005Sep 30, 2005Dec 31, 2005Mar 31, 2006Jun 30, 2006Sep 30, 2006Dec 31, 2006Mar 31, 2007Aug 29, 2007Nov 28, 2007Feb 25, 2008May 28, 2008Sep 3, 2008Dec 3, 2008Feb 23, 2009Jun 3, 2009Sep 2, 2009Dec 2, 2009Mar 1, 2010Jun 2, 2010Sep 1, 2010Dec 1, 2010Feb 28, 2011Jun 1, 2011Aug 31, 2011Nov 30, 2011Feb 27, 2012May 30, 2012Aug 29, 2012Nov 28, 2012Feb 25, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 24, 2014May 28, 2014Sep 3, 2014Dec 3, 2014Feb 24, 2015Jun 3, 2015Aug 25, 2015Nov 20, 2015Feb 23, 2016May 18, 2016Aug 23, 2016Nov 18, 2016Feb 28, 2017May 22, 2017Aug 25, 2017Nov 17, 2017Feb 28, 2018May 28, 2018Aug 27, 2018Nov 16, 2018Feb 18, 2019May 27, 2019Aug 27, 2019Nov 27, 2019Feb 13, 2020May 25, 2020Aug 13, 2020Nov 12, 2020Feb 22, 2021May 3, 2021Aug 17, 2021Nov 18, 2021Feb 15, 2022May 17, 2022Aug 16, 2022Nov 9, 2022Feb 23, 2023May 22, 2023Aug 24, 2023Nov 7, 2023Feb 22, 2024May 23, 2024Aug 15, 2024Nov 8, 2024Feb 20, 2025May 15, 2025Aug 13, 2025Nov 7, 2025Feb 18, 2026May 19, 2026Aug 11, 2026
EPS Estimate-----------------------------------------------------------------------------------------
EPS Actual0.010.010.010.010.010.010.010.010.010.010.010.010.010.010.020.010.010.010.010.010.010.010.130.010.010.010.010.010.010.010.010.010.010.010.010.010.020.010.010.010.010.010.020.020.010.020.030.010.000.010.010.010.010.010.010.010.010.010.020.020.020.020.010.010.020.020.020.020.020.020.020.020.020.020.020.020.010.010.010.020.020.020.020.030.020.020.020.030.03
Surprise-----------------------------------------------------------------------------------------
Timing------------------------------------------------------------------------Pre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap1.10B
Enterprise Value1.33B
Trailing P/E10.36
Forward P/E10.49
PEG Ratio0.91
Price / Sales1.18
Price / Book1.42
EPS0.11
Book Value0.817
Revenue (TTM)929.41M
Gross Profit (TTM)383.56M
EBITDA188.53M
Profit Margin11.00%
Operating Margin18.71%
Return on Equity13.43%
Return on Assets6.61%
Shares Outstanding961.94M
Shares Float529.68M
Beta0.36
Dividend Yield3.99%
Dividend Rate0.05
Payout Ratio42.80%

Dividends

20262×
0.01Sep 3, 20260.03Mar 12, 2026
20252×
0.01Sep 8, 20250.02Mar 5, 2025
20242×
0.01Aug 29, 20240.02Mar 7, 2024
20232×
0.01Sep 8, 20230.02Apr 7, 2023
20222×
0.01Aug 29, 20220.02Apr 14, 2022
20212×
0.00Aug 30, 20210.04Apr 21, 2021
20202×
0.00Aug 28, 20200.04Jul 13, 2020
20192×
0.01Oct 15, 20190.03Jun 26, 2019
20182×
0.01Nov 2, 20180.02Jun 13, 2018
20172×
0.01Oct 17, 20170.01May 26, 2017
20162×
0.01Oct 19, 20160.02Jun 6, 2016
20152×
0.01Oct 13, 20150.03May 27, 2015

Stock Splits

  • Sep 6, 20214:3
  • Jun 14, 2018322782:138335
  • Jun 18, 2015746:553
  • Jul 12, 2004196106:89139
  • Oct 8, 20036:5